Utility of ACR TI‐RADS to determine need for repeat FNA in thyroid nodules with nondiagnostic cytology

Authors:

Abstract
Background: Nondiagnostic cytology for thyroid nodules, consistent with The Bethesda System for Reporting Thyroid Cytopathology category I (B1) poses a management dilemma for clinicians. The objective of this study was to define the malignancy risk of nodules with B1 cytology using American College of Radiology Thyroid Imaging Reporting & Data System (TI‐RADS) and to assess whether TI‐RADS can help guide the decision to perform a repeat biopsy of these nodules. Materials and methods: This retrospective cohort study evaluated 139 B1 nodules that had a definitive diagnosis on repeat biopsy or surgical excision. Sonographic features were evaluated and classified according to TI‐RADS. TI‐RADS category and total points were compared to the final diagnosis to determine the malignancy risk of B1 thyroid nodules. Results: Of the 139 nodules, 11 (7.9%) were malignant. The malignancy risk of nodules assigned TI‐RADS category 1 and 2 were both 0%, TI‐RADS 3 was 2.9%, whereas TI‐RADS 4 and 5 were 5.9% and 46.2%, respectively. The optimal cutoff for TI‐RADS points predicting malignancy was 5 points. Conclusion: B1 thyroid nodules in TI‐RADS categories 1–3 may not require repeat biopsy given low malignancy risk. However, B1 nodules in TI‐RADS categories 4 and 5 have a higher malignancy risk and thus should undergo repeat biopsy.

This publication has 14 references indexed in Scilit: